AI assistant
ADVANCED MEDICAL SOLUTIONS GROUP PLC — Director's Dealing 2013
Sep 16, 2013
7467_dirs_2013-09-16_d6eab169-505a-45f2-854c-9647b3f1b6b2.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 0888O
Advanced Medical Solutions Grp PLC
16 September 2013
16 September 2013
Advanced Medical Solutions Group plc ("AMS" or the "Company")
Exercise of share options and Directors' dealings
Advanced Medical Solutions Group plc (AIM:AMS), the global medical technology company, today announces that following the successful achievement of certain performance criteria, the following options from certain share incentive schemes have been exercised as outlined below.
To cover in part the exercise cost and the tax payable on this exercise Mary Tavener, Finance Director, has sold Ordinary Shares of 5p each on 13 September 2013 as detailed below.
Long Term Incentive Plan (LTIP)
| Director | No. of LTIPs prior to exercise | LTIPs exercised | Ordinary shares sold | LTIPs after exercise |
| Mary Tavener, Finance Director | 530,049 | 168,969 | 168,969 | 361,080 |
Deferred Share Bonus Plan (DSB)
| Director | No. of DSBs prior to exercise | DSBs exercised | Ordinary shares sold | DSBs after exercise |
| Mary Tavener, Finance Director | 135,488 | 118,422 | 118,422 | 17,066 |
In addition, Mary Tavener has sold 315,559 ordinary shares of 5p each.
As a result of these transactions Mary Tavener's beneficial interest in the Company has decreased from 2,088,601 shares to 1,773,042 shares.
| Director | Holding prior to exercise | Number of shares exercised | Number of shares sold | Sale Price(p) | Resultant holding | % of issued share capital |
| Mary Tavener Finance Director | 2,088,601 | 287,391 | 602,950 | 85.056p | 1,773,042 | 0.86 |
For further information:
Advanced Medical Solutions Group plc
Mary Tavener, Group Finance Director +44 (0) 1606 545 508
Investec (NOMAD)
Daniel Adams +44 (0) 20 7597 5970
END
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSDMGMLZVFGFZM